Skip to main page content

Dr. Lynn Gordon

Participates in 6 items

Lynn K Gordon, MD, PhD is Professor Emerita of Ophthalmology at the Stein Eye Institute and was the Inaugural Senior Associate Dean for Equity and Diversity Inclusion at the David Geffen School of Medicine at UCLA. Following her undergraduate training at Stanford University, she completed both the MD and PhD at Harvard University, and residency in ophthalmology and fellowship training in neuro-ophthalmology at UCLA. 

She is an active clinician scientist whose work has resulted in multiple patents and more than 100 publications, book chapters, and reviews. Dr. Gordon had held multiple leadership positions including being a current member of the board of the North American Neuro-Ophthalmology Society, past president of the California Academy of Eye Physicians and Surgeons, past president of Women in Ophthalmology, past chair of the steering committee of the Group on Women in Medicine and Science (GWIMS) of the AAMC,  past member of the Board of Trustees and past Chair of the Council of the American Academy of Ophthalmology. She helped create multiple faculty development and leadership programs at UCLA and the Association for Research in Vision and Ophthalmology (ARVO).  Her greatest passion is helping individuals realize their full potential.


Financial disclosure: Dr. Gordon has/had an affiliation (financial or otherwise) with a commercial organization:

  1. Regeneron
  2. Vedere Bioscience

Sessions in which Dr. Lynn Gordon participates

Friday 16 June, 2023

Time Zone: (GMT-05:00) Eastern Time (US & Canada)
8:00 AM
8:00 AM - 10:00 AM | 2 hours
Current Concepts

 Learning Objectives:At the end of this session, participants will be able to:Review how to apply Quality Improvement strategies to improve patient safetyBe familiar with the presentation and histology of hereditary benign intraepithelial dyskeratosis, and be able to distinguish it from other conjunctival lesions including conjunctival intraepithelial neoplasia.Des...

8:45 AM
8:47 AM - 8:57 AM | 10 minutes
Keynote SpeakerNeuro-ophthalmology
10:45 AM
10:45 AM - 12:15 PM | 1 hour 30 minutes

 Learning Objectives: At the end of this session, participants will be able to: Describe the presenting signs and symptoms, as well as evaluation and management of Giant Cell ArteritisExplain the therapeutic options for central retinal artery occlu...

1:30 PM
1:30 PM - 3:00 PM | 1 hour 30 minutes

 Learning Objectives: At the end of this session, participants will be able to: Explain the mechanism of action of the major immune checkpoint inhibitors currently used in cancer immunotherapyDiscuss the